Patrick G. Lepore

Patrick G. Lepore, listed as board member, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Lannett Co Inc, Yarrow Bioscience, Inc. and Matinas BioPharma Holdings, Inc. We count 32 filings; the first trade dates from 17 June 2016 and the latest from 15 January 2025.

Purchases make up the whole of the open-market record (23 purchases, €2.0M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 8 share grants. So far in 2025, the count stands at 1 purchase and no sales.

A typical purchase (the median) is worth €68k. 10 out of 23 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 16 January 2025, the filings show an open-market purchase worth €42k in Yarrow Bioscience, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.